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Hyphema. Part I. Pathophysiologic Considerations
Abstract
Hemorrhage in the anterior chamber of the eye, or hyphema, results from a breakdown of the blood-ocular
barrier (BOB) and is frequently associated with inflammation of the iris, ciliary body, or retina. Hyphema can
also occur by retrograde blood flow into the anterior chamber via the aqueous humor drainage pathways
without BOB breakdown. Hyphema attributable to blunt or perforating ocular trauma is more common than
that resulting from endogenous causes. When trauma has been eliminated as a possible cause, it is prudent to
assume that every animal with hyphema has a serious systemic disease until proven otherwise.
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FOCAL POINT 
Hyphema is frequently associated 
with iridocyclitis and generally 
indicates severe intraocular or 
systemic disease. 
KEY FACTS 
Athorough diagnostic evaluation 
should be initiated when 
hyphema is present, p. 1064. 
Hyphema generally results from 
a breakdown of the blood-ocular 
barrier, p. 1064. 
The diagnostic differentials 
for hyphema do not differ 
substantially from those for 
hemorrhage into other areas 
of the body, p. 1065. 
When trauma has been 
eliminated as source of hyphema, 
the diagnostic and therapeutic 
approach is directed by results 
of the physical and ophthalmic 
examinations, p. 1065. 
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ABSTRACT: Hemorrhage in the anterior chamber of the eye, or hyphema, results from a break· predi. 
down of the blood-ocular barrier (BOB) and is frequently associated with inflammation of the the al 
iris, ciliary body, or retina. Hyphema can also occur by retrograde blood flow into the anterior 
chamber via the aqueous humor drainage pathways without BOB breakdown. Hyphema at· PAntributable to blunt or perforating ocular trauma is more common than that resulting from en· Widogenous causes. When trauma has been eliminated as a possible cause, it is prudent to as­
agnossume that every animal with hyphema has aserious systemic disease until proven otherwise. 
tially 
H 
body 
)'Phema is defined as hemorrhage within the anterior chamber of the eye diagn 
(Figure 1). In contrast, the accumulation of leukocytes in the ;:nterior hyphl 
chamber is termed h)'P0pyon. The etiopathogenesis of hyphema is mul­ dison 
tifactorial, but ultimately the final common pathway is breakdown of the soum 

blood-ocular barrier (BOB) and subsequent inrraocular hemorrhage that is of­ so thl 

ten associated with inflammation. Many of the mechanisms that cause intraocu­ ation: 

lar hemorrhage may also result in hemorrhage in other parts of the body. This I1Ism~ 

article foclIses on hyphema as a "red flag" for sight-threatening ocular or life­

threatening systemic hemorrhagic disease. Irido 

When hyphema is present, a thorough diagrwstic evaluation similar ro that in­ lri( 
dicated for any third-compartment hemorrhage (e.g., hemoabdomen, hemotho­ ocula 
rax) should be initiated. Attentive clinicians will recognize the importance of a aque( 
thorough diagnostic workup before or during the initial treatment of hyphema. ner I 
. ,Death attributable to systemic or vital organ hemorrhage may occur if the diag­ terns) 
nostic workup is incomplete. Part I of this two-parr presentation focuses on the rncltJ 
many pathophysiologic mechanisms that most frequenrly result in hyphema, the f 
each of which is considered as a separate entity in this article. However, concur­ discu 
rent involvement of more than one mechanism is common. Part II will cover di­ ble c 
agnosis and treatment of hyphema. left L 
cyclil 
BLOOD-OCULAR BARRIER cei'ls 
The BOB, which consists of the blood-aqueous and blood-retinal barriers, pre­
vents erythrocytes and leukocytes and inhibits tissue fluids and proteins from enter­ Trau 
ing nonvascular ocular tissues and compartments. The BOB consists of endothelial H~ 
- ------ - - -- - - - - - -- - - ---
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and epithelial tight junctions 
with variations in their degree 
of permeability. l Dysfunction 
of the blood-aqueous barrier 
frequently results in hyphe­
rna; breakdown of the 
blood-r.-:tinal barrier general­
ly causes retinal, subretinal, 
and choroidal hemorrhage 
but infrequently results in 
hyphema. The posterior lens 
capsule and zonules limit but 
do not com pletely preven t 
movement of blood from the 
anterior chamber to the vitre­
ous and vice versa. 
Figure 1-Hyphema in a dog. 
Because the intraocular pressure (lOP) is normally 
higher than the pressure in the aqueous humor drain­
age pathways (the scleral venous plexus), retrograde 
blood flow into the anterior chamber is prevented. lOP 
lower than the pressure in the scleral venous plexus may 
predispose to hyphema via retrograde blood flow into 
the anterior chamber. 
PATHOPHYSIOLOGIC APPROACH 
With the exception of severe intraocular disease, the di­
agnostic differentials for hyphema do not differ substan­
tially from those for hemorrhage in other areas of the 
body (e.g., hemothorax. hemoabdomen); therefore, the 
diagnostic approach to determine the underlying cause of 
hyphema is similar. In addition to systemic causes, ocular 
disorders should be considered. Clinicians must develop a 
sound understanding of the potential causes of hyphema 
so they are able to construct a list of differential consider­
ations for each mechanism. The most common mecha­
nisms of hemorrhage that may result in hyphema follow. 
Ir.idocyclitis 
Iridocyclitis (anterior uveitis) is the most common 
ocular disease associated with a breakdown of the blood­
aqueous barrier. Disruption of the blood-aqueous bar­
rier may lead to aqueous flare (predominantly pro­
teins), hypopyon, and/or hyphema, depending on the 
inciting stimulus and duration of the disease. Most of 
the pathophysiologic mechanisms of BOB breakdown 
discussed in the remainder of this article are also possi­
ble causes for iridocyclitis. Regardless of the caLIse, ,if 
left untreated, hyphema will eventually result in irido­
cyclitis when chemotactic triggers recruit inflammatory 
cells for cleanup. 
Trauma 
Hyphema attributable to exogenous causes (blunt or 
perforating trauma) is prob­
ably more common than that 
resulting from endogenous 
causes (see Causes of Hyphe­
rna) . Blunt trauma to the 
head seldom resuhs in hyphe­
rna because the eyebal'l is pro­
tected by anterior portions 
of the bony orbit and orbital 
soft tissues. However, severe 
blunt trauma to the anterior 
orbital rim or periorbital soft 
tissues and eyeball may re­
suit in hyphema. In this case, 
-- - - - - -- - -- - -- - -- -- - - - - examination and palpation 
of the periorbital area usual­
I,y reveals clinical signs of trauma, such as swelling and 
bruising of the eyelids and conjunctiva, fracture of the 
bony orbit, or orbital hemorrhage and resultant orbital 
mass effect. Bilateral hyphema is seldom caused by 
mild trauma. When blunt ocular trauma occurs, the 
sudden rise in lOP associated with ocular indentation 
causes anterior chamber angle distortion and may result 
in rupture of iris stromal or ciliary body vessels and 
subsequent hyphema.4 
Perforating trauma (e.g., cat scratch, BB pellets) to 
the eye baH (cornea, sclera) with direct damage to in­
traocular vasculature is more likely to result in trau­
matic hyphema than is blunt trauma. Traumatic hy­
phema can also be associated with proptosis of the 
globe and may be accompanied by structural damage 
to the eye, including lens subluxation and dislocation, 
vitreous hemorrhage, or retinal detachment. ' Head ra­
diographs help to reveal fractures of the orbit or skull 
in trauma cases. When exogenous sources of hyphema 
have been eliminated, the diagnostic approach is fur­
ther directed by results of physical and ophthalmic ex­
amll1atIons. 
Thrombocytopenia 
Lack of an adequate number of circulating platelets 
can result in hyphema and hemorrhage secondary to 
ongoing capi,uary microtrauma induced by normal ac­
tiviry or exogenous insult.6 Thrombocytopenia is typi­
fied clinically by petechial hemorrhage of mucosal and 
cutaneous surfaces. Hyphema and concurrent petechial 
hemorrhages should prompt clinicians to consider 
thrombocytopenia as a likely mechanism of disease. 
Thrombocywpenia may be induced by immune-medi­
ated destruction of platelets, infectious agents (e.g., 
Ehrlichia canis, platys, or risticii; Leptojpira species; 
Rickettsia rickettsil) , sepsis, splenomegaly, neoplasia, or 
disseminated intravascular coagulation . 
ANTERIOR UVEITIS • PERFORATING TRAUMA PETECHIAL HEMORRHAGE 
· 
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Causes of Hyphema 
Trauma2-5 
• 	 Blunt 
• 	 Penetrating (with or without foreign body) 
Thrombocytopenia6-10 
• Decreased platelet production in the bone marrow 
-Drug or chemical toxicity-induced bone marrow 
hypoplasia (e.g., estrogens, antiinflammatory 
agents, antibiotics, tranquilizing agents, diuretic 
agents, dapsone, myelosuppressive chemotherapy) 
-Toxic doses of irradiation 
-Chronic infections (e .g., feline leukemia virus 
[FeLV], Ehrlichia canis, Ehrlichia platys, canine 
distemper, parvovirus, heartworm disease) 
-Myeloproliferative disorders (e.g., FeLV, feline 
immunodeficiency virus [FIV]), lymphoma, tumor 
metastasis 
-Estrogen-secreting tumors (e.g ., Sertoli cell tumor) 
-Myelofibrosis 
-Immune-mediated megakaryocytic hypoplasia or 
aplasia 

-Chronic renal disease 

• 	 Reduced circulating platelet life span 
-Sequestration (e.g., splenomegaly) 
-Immune-mediated platelet destruction 
-Nonimmunologic platelet destruction 
• 	Microangiopathic thrombocytopenia (e.g., 
disseminated intravascular coagulation [DIG], 
tumor microvasculature [hemangiosarcoma, 
hepatic tumors]) 
• 	Microangiopathic hemolytic anemia 
• 	Severe vascular injury and vasculitis (see 
Vasculitis and uveitis) 
• 	Drug-induced (e.g., heparin) 
• 	Platelet loss via hemorrhage (usually mild 
thrombocytopenia) 
• 	Infectious agents (e.g ., E. canis, Rickettsia 
rickettsii, Dirofilaria) 
Thrombocytopathy (defects in platelet adhesion, 
aggregation, or release reactions)'o", 
• 	 Inherited: von Willebrand's disease and other 
hereditary thrombopathias, including breed-specific 
thrombopathias 
• 	 SystemiC illness: Uremia, collagen deficiency disease, 
hepatic disease, pancreatitis, ehrlichiosis (E. canis, 
£. platys) , FeLV, dysproteinemia, gammopathies, 
myeloproliferative/myelodysplastic disorders, DIG, 
Iymphoproliferative disorders, multiple myeloma 
• 	 Drug-induced: NSAIDs, corticosteroids, diuretic 
agents, tranquilizers, synthetic colloid solutions 
(e.g., dextran), 0:- and ~-blockers and stimulators, 
hormonal agents (e.g., prostacyclin , estrogen), vinca 
alkaloids, antibiotics and antiparasitic agents, heparin 
• 	 Antibody-mediated platelet dysfunction: Immune­
mediated thrombocytopathy, systemic lupus 
erythematosus 
Coagulopathy 8.10.12-14 
• 	 Inherited 
• 	 Acquired 
Vasculitis and uveitisl 5-21 
• 	 Infectious: Rocky Mountain spotted fever, 
ehrlichiosis, leptospirosis, brucellosis, piroplasmosis, 
leishmaniasis, ophthalmomyiasis interna, ocular 
filariasis (Dirofilaria immitis) , tuberculosis, 
geotrichosis, protothecosis, toxoplasmosis 
(Toxoplasma gondii), FIV, FeLV, feline infectious 
peritonitis (FIP), canine adenovirus 1, cryptococcosis, 
blastomycosis, coccidioidomycosis, candidiasis 
• 	 Immune-mediated (e.g ., uveodermatologic syndrome) 
• 	 Neoplasia (e.g., lymphosarcoma, ocular sarcoma, 
metastatic tumors) 
• 	 Lens-induced uveitis 
• 	 Episcleritis 
• 	 SystemiC inflammatory response syndrome: SepSiS, 
endotoxemia (e.g., pyometra) 
• 	 Secondary to keratitis or trauma 
• 	 Idiopathic 
Noninflammatory vascular disorders22 
• 	 Hyperadrenocorticism 
• 	 Ehlers-Danlos syndrome 
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Causes of Hyphema (continued) 
Hyperviscosity syndrome9.23-27 
• 	 Mono- or polyclonal gammopathies: Multiple 
myeloma, lymphoma, leukemia, chronic inflammation, 
antigenic stimulation (e.g., dirofilariasis), FIV, FIP, 
ehrlichiosis (E. canis, E. platys) 
• 	 Severe erythrocytosis: Hemorrhagic gastroenteritis, 
polycythemia vera, erythropoietin-secreting neoplasms 
Systemic hypertension 28-30 
Neovascularization of uveal and retinal tissues 
• 	 Retinal detachment'61831-JJ 
-Primary 
-Secondary: Lenticular disease, infectious diseases 
(see Vasculitis and uveitis), nonseptic inflammation 
(see Vasculitis and uveitis), trauma (see Trauma), 
intraocular neoplasia (see Neoplasia), systemic 
neoplasia (e.g., multiple myeloma), systemic 
hypertension (i.e., hypertensive retinopathy; see 
Thrombocytopathy 
Defects in platelet adhesion, aggregation, or release 
can result in ineffectual platelet function. II These de­
fects may be inherited (e.g., von Willebrand's disease); 
be induced by systemic disorders; or, as in most ac­
quired cases, occur as an idiosyncratic reaction to cer­
tain drugs (see Causes of Hyphema). Thrombocytopa­
thy should be suspected in patients with hemorrhagic 
tendency, prolonged bleeding time, appropriate platelet 
count, and normal tests of secondary hemorrhage. 
Coagulopathy 
Abnormalities of the intrinsic, extrinsic, or common 
pathways of the clotting cascade may result in clotting 
abnormalities and subsequent hemorrhage and hyphe­
mao Coagulopathies are typified clinically by large 
third-compartment or major organ hemorrhages (e.g., 
body cavity, pulmonary, musde/deep tissue) and may 
be inherited or acquired. Although ecchymotic hemor­
rhages are classically described in coagulopathies, cuta­
neous hemorrhages are less common in animals with 
coagulopathies than are thrombocyropenias and throm­
bocytopathies. Clinical presentation is extremely vari­
able depending on the site of hemorrhage. Secondary 
signs of anemia (weakness, pallor) are often noted by 
owners of animals with a coagulopathy. 
Systemic Hypertension section in text), congenital 

abnormalities (e.g., retinal dysplasia), senile 

degenerative changes 

• 	 Chronic glaucoma'6 
• 	 Intraocular neoplasia34 
-Primary: Lymphosarcoma, adenoma and 

adenocarcinoma, melanoma, posttraumatic 

ocular sarcoma in cats 

-Secondary: Adenocarcinoma, transitional cell 

carcinoma, lymphoma, multiple myeloma 

Congenital anomalies 31.35 
• 	 Collie eye anomaly 
• 	 Vitreoretinal dysplasia (e.g., in Bedlington terriers, 
Sealyham terriers, Labrador retrievers) 
• 	 Persistent hyaloid artery (e.g., with persistent 
hyperplastic primary vitreous in Doberman pinschers) 
Anemia 
Vasculitis 
Vascular endothelial cell abnormalities may result in 
transmural extravasation of blood from vascular chan­
nels in the iris and ciliary body, resulting in breakdown 
of the blood-aqueous barrier and hyphema. Vasculitis 
may result from primary or secondary immune-mediat­
ed destruction of endothelial cells (e.g., immune-medi­
ated vasculitis, toxoplasmosis), infectious diseases (e.g., 
leptospirosis, Rocky Mountain spotted fever, feline in­
fectious peritonitis), neoplasia, or systemic inflammato­
ry response syndrome (e.g., sepsis). Noninflammatory 
vascular disorders, including hyperadrenocorticism and 
Ehler-Danlos syndrome, can also result in hemorrhage. 
Hyperviscosity Syndrome 
Diseases that produce excessive globulins or other plas­
ma proteins may result in hyphema because of (1) vascu­
lar endothelial cell compromise caused by intravascular 
sludging of blood with vessel wall necrosis, (2) infiltra­
tion of proteins into the vessel wall, (3) inhibition of 
hemostasis secondary to reduction in clotting factors, 
and/or (4) coating of platelets by abnormal paraproteins 
resul ring in abnormal platelet aggregation. 23 Funduscopic 
examination of the contralateral eye may reveal engorged 
retinal vasculature and retinal hemorrhages. Common 
causes of hyperviscosity include plasma cell myeloma, 
ECCHYMOTIC HEMORRHAGE • NONINFLAMMATORY VASCULAR DISORDERS • PLASMA PROTEINS 
I 
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lymphoma, ehrlichiosis, and chronic inflammatory dis­ cell and fibroblast proliferation and subsequent ftbrovas­ often 
ease. Serum total solids will generally be excessively ele­ cular membrane formation ..l6 The most frequent site of intrao 
vated because of hyperglobulinemia. Hyperviscosity syn­ fibrovascular membrane formation in eyes with chronic older; 
drome can also be induced by severe erythrocytosis, such retinal detachment is overlying the anterior iris surface glOsar, 
as hemorrhagic gastroenteritis, po'lycythemia vera , and (pre-iridal ftbrovascular membrane). 16 Acute hyp hema montl­
erythropoietin~secreting neoplasms. may occur if the retinal vasculature tears when the neu­ unilatc 
rosensory retina detaches from the underlying retinal traoCI 
SystemiC Hypertension pigment epithelial cells. Clinicians must derermine the intrao 
Hyphema arrributable to systemic hyperrension is cause of the retinal detach­ ondaI"' 
most common in old cats and dogs and is often caused ment because life-threaren­ oma) 
by chronic renal insufftciency. Systemic hypertension ing systemic disease may be suit in 
affects only the arterial vascular system. Chronic high the underlying abnormality 
arterial pressure may result in arteriosclerosis and au­ (see Causes of Hyphema) . in Cong 
toregulatory arteriolar vasospasm. Arteriolar disease our experience, sponrane­ H)'! 
causes ischemia and capillary permeability changes ous (idiopathic) retinal de­ to cor 
(with leakage of plasma proteins) and eventually hem­ tachment is rare in dogs and cawse. 
The more commoll causes of
orrhage. In our experience, most cases of hyphema cats and an underlying cause is cha 
illtraocular hemorrhage werefrom vasoular hypertension are attribu table to retinal is usually present. tribU[; 
detachment (see Neovascularization of Uveal and Reti­ severekllown 20 years ago. Since then, 
nal Tissues section) and most likely occur in response Chronic Glaucoma new infictiom causes of rerrler 
to choroidal vascular hypertension. Hyphema may be Pre-iridal fibrovascular hyp"ema, such as felille er spa 
less commonly caused by tearing of retinal vasculature membranes are also frequent­ immunodeficiency virus, have plere 
that occurs during retinal detachment. Otber common ly detected in eyes with been detected. Research Oller the subse< 
causes of vascular hypertension include hyperthyroidism , chronic (end-stage) glauco­ and vpast 20 years has demollstrated 
hyperadrenocorticism , hyperaldosteronism, and pheo­ ma. ,G It is likely that hyphe­ curs smarty mediators of 
chromocytoma. ma attributable to chronic fetal r
neollasclilarizatiort and 
glaucoma occurs secondary tent hintraocular inflammation. TheNeovascularization of Uveal and Retinal Tissues to tearing and leakage of the body,
methodologies for diAgnosticAlthough the presence of blood vessels is necessary in fragile pre-iridal mlcrovascu­
workup hmle improved with themost tissues, neovascularization or angiogenesis of tissues lature.' f, Anen 
advent ofB-modecan cause severe disease. The surfaces of the retina and Acc 
iris are vulnerable to symptomatic neovasCldarization..l6 Intraocular Neoplasia ultrasonography, computed severe 
Possible causes for neovascularization are ischemia (in­ Growth of a neoplasm larg­ l tomography, and magnetic can cc 
cluding long-standing retinal detachment), intraocular er than 2 to 3 mm-l requires resonallce imaging. Howeller, low 5 
neoplasia, and inflammation. \6 Vascular proliferation on development of a microvas­ the primar), management issues dothe 
the anterior iris surhce (rubeosis iridis) leads to the for­ cular network to facilitate vessel:ofhyphema halle remained 
mation of a pre-iridal ftbrovascular membrane, which delivery of nutrients and unchartged. A few new 
can involve the peripheral iris and iridocorneal drainage oxygen and removal of treatment OptiOIlS have been 
angle and result in obstruction of aqueous humor out­ catabolites. 38 Primary and 
added, such as tissue 
flow. Angiogenesis, a complex process that incllldes metastatic intraocular neo­ I. B(
plasminogm actillator and 
mdegradation of extracellular matrix and endothelial cell plasms of the anterior uveal 
topical carbonic anhydrllSe thproliferation , is stringently regulated by numerous tissues are highly vascular. 
2. \l(­inhibitors. UnfortulUltely, theproangiogenic and antiangiogenic factors. Examples of These neoplasms secrete 
mprognosis for main fair-ling lIisiollgrowth factors that stimulate endothelial cell prolifera­ vascular growth factors (e.g., 3. \l(­
tion include fibroblast growth factors, insulinlike growth VEGF, TGF-~) that stimu­ in an eye with hyphema has Ai 
factors, transforming growth factor-~ (TGF-~), and vas­ late formation and rapid generally remained the Sf/me 4. G 
cular endothelial growth factor (VEGF).lG The newly growth of vessels to support oller the past 20 years. H 
grown vessels are exceedingly fragile, leal( readily, and can and sustain rumor growthY 5. G 
pIpotentially result in hemorrhage and hyphema;17 Newly developed capillaries 
2(
of neoplasms are prone to 6. MRetinal Detachment hemorrhage because they p, 
Long-standing retinal detachment stimulates produc­ have incomplete basement 
tion of growth factors that induce vascular endothelial membranes, are leaky, and 7. Jo 
ARTERIOLAR DISEASE . PRE-IRIDAL FIBROVASCULAR MEMBRANE . GROWTH FACTORS 
15 
I 
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often fracture . J6 ..lS Animals with hyphema attributable to 
intraocular neoplasia are usually in late middle age or 
older; however, we have diagnosed ciliary body heman­
giosarcoma and iris melanoma in dogs as young as 7 
months of age. Most primary inrraocu'lar neoplasms are 
unilateral, and thus hyphema attributable to primary in­
traocular neoplasia is unilateral. Bilateral primary 
intraocular neoplasms are reponed infrequenrly.j~ Sec­
ondary or metastatic intraocular neoplasia (e.g., lymph­
oma) may affect one or both eyes and may -therefore re­
sult in unilateral or bilateral hyphema. 
Congenital Ocular Anomalies 
Hyphema in young animals should prompt clinicians 
to consider congenital ocular malformation as a ilikely 
cause. Collie eye anomaly, which is recessively inherited, 
is characterized by defects of the choroid and sclera at­
tributable to abnormal mesodermal differentiation.5J In 
severe cases of vitreoretinal dysplasia (e.g., in Bedlington 
terriers, Sealyham terriers, Labrador retrievers, or spring­
er spaniels), retinal folding is sufficient to permit com­
plete retinal detachmenr. 3 1.35 Retinal detachment and 
subsequent hyphema may occur w~h collie eye anomaly 
and vitreoretinal dysplasia. Persistent hyaloid artery oc­
curs sporadically in dogs and is caused by failure of the 
fetal hyaloid vasculature to regress. l5 Rupture of a persis­
tent hyaloid artery leads to hemorrhage into the vitreolls 
body, with blood passing into the anterior chamber. l5 
Anemia 
According to our experience and a previous report, 40 
severe acute anemia (e.g., severe tick or flea infestation) 
can cause hyphema when hemoglobin rapidly drops be­
low 5 mg/dl. Insufficient oxygen supply may cause en­
dothelial cells to die, which leads to leaking of blood 
vessels. 
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